Silver Book Fact

Anti-VEGF Letter Improvement

Fact image

An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.

Brown D, Nguyen Q, Marcus D, Boyer D, et al. Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-month results from two phase III trials: RISE and RIDE. Ophthalmol. 2013. http://www.aaojournal.org/article/S0161-6420(13)00212-1/abstract. Accessed May 17, 2016

Reference

Title
Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-month results from two phase III trials: RISE and RIDE
Publication
Ophthalmol
Publication Date
2013
Authors
Brown D, Nguyen Q, Marcus D, Boyer D, et al.
Volume & Issue
Volume 120, Issue 10
Pages
324-30
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Medicines Reduce Complications of Diabetes: Diabetes patients treated with medicines are less likely to develop other health problems  
  • In a trial with 160 participants who had type 2 diabetes, intensive intervention with multiple drug combinations and behavior modification benefited patients with respect to vascular complications and on rates…  
  • A recent study conducted by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) so clearly demonstrated that lifestyle interventions reduced the risk of developing type 2 diabetes…  
  • Widespread use of diabetes prevention drugs that enhance insulin sensitivity could result in a 50% prevention of type 2 diabetes over a 10 to 15 year period.  
  • Mobile Exam for DR
    Use of a mobile examination for DR screening in Finland decreased visual impairment by 86% in the covered area.